ATC code P02

ATC code P02 Anthelmintics is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3] Subgroup P02 is part of the anatomical group P Antiparasitic products, insecticides and repellents.[4]

ATC code P: Antiparasitic products, insecticides and repellents
Human only
P01 Antiprotozoals P02 Anthelmintics P03 Ectoparasiticides, including scabicides, insecticides and repellents
ATCvet only
QP51 Antiprotozoals QP52 Anthelmintics QP53 Ectoparasiticides, including insecticides and repellents QP54 Endectocides
Other ATC codes
A B C D G H QI J L M N P R S V

National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.

P02B Antitrematodals

P02BA Quinoline derivatives and related substances

P02BA01 Praziquantel

P02BA02 Oxamniquine

P02BB Organophosphorous compounds

P02BB01 Metrifonate

P02BX Other antitrematodal agents

P02BX01 Bithionol

P02BX02 Niridazole

P02BX03 Stibophen

P02BX04 Triclabendazole

P02C Antinematodal agents

P02CA Benzimidazole derivatives

P02CA01 Mebendazole

P02CA02 Tiabendazole

P02CA03 Albendazole

P02CA04 Ciclobendazole

P02CA05 Flubendazole

P02CA06 Fenbendazole

P02CA51 Mebendazole, combinations

P02CB Piperazine and derivatives

P02CB01 Piperazine

P02CB02 Diethylcarbamazine

P02CC Tetrahydropyrimidine derivatives

P02CC01 Pyrantel

P02CC02 Oxantel

P02CE Imidazothiazole derivatives

P02CE01 Levamisole

P02CF Avermectines

P02CF01 Ivermectin

P02CX Other antinematodals

P02CX01 Pyrvinium

P02CX02 Bephenium

P02CX03 Moxidectin

P02D Anticestodals

P02DA Salicylic acid derivatives

P02DA01 Niclosamide

P02DX Other anticestodals

P02DX01 Desaspidin

P02DX02 Dichlorophen

References

"ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
"Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
"ATC/DDD Index 2022: code P02". WHO Collaborating Centre for Drug Statistics Methodology.

Antiparasitics – Anthelmintics (P02) and endectocides (QP54)

Antiplatyhelmintic agents

Antitrematodals
(schistosomicides)

Binds tubulin	benzimidazole Triclabendazole^#
AChE inhibitor	phosphonic acid Metrifonate^‡
Other/unknown	quinoline Praziquantel^# Oxamniquine^# phenol Bithionol thiazole Niridazole thioxanthone Hycanthone Lucanthone antimony compounds Stibophen Tartar emetic^‡

Anticestodals
(taeniacides)

Binds tubulin	benzimidazole Albendazole^#
Other/unknown	quinoline Praziquantel^# salicylanilide Niclosamide^# aminoacridine Quinacrine butyrophenone Desaspidin chlorophenol Dichlorophen

Antinematodal agents
(including
macrofilaricides)

Binds tubulin	benzimidazole Mebendazole^# Albendazole^# Tiabendazole Fenbendazole Ciclobendazole Flubendazole
Glutamate-gated chloride channel, GABA receptor	avermectins Abamectin Doramectin Emamectin Eprinomectin Ivermectin^# Selamectin milbemycins Moxidectin Milbemycin oxime
NMDA	tetrahydropyrimidine Pyrantel^# pyrantel pamoate Oxantel Morantel Carbantel Febantel (aka felsantel)
Other/unknown	piperazine Piperazine Diethylcarbamazine^# thiazole Levamisole^# quinolinium Pyrvinium benzylammonium Bephenium naphthalenesulfonate Suramin^# Ascaridole^‡ Hexylresorcinol Santonin^‡ Tribendimidine Tetrachloroethylene^‡

^#WHO-EM
^‡Withdrawn from market
Clinical trials:
- ^†Phase III
- ^§Never to phase III

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.